Abstract
We have previously reported our experience with the use of alternate-day prednisone in the treatment of 6 patients with IgA nephropathy who have clinical or pathological risk factors for disease progression. We have now treated a total of 13 patients and followed them from 4 to 10 years. Patients received an alternate-morning dose of prednisone for 2–4 years. Dosage began at 60 mg/m2 for 3 month, was reduced to 30 mg/m2 by 1 year and 15 mg/m2 by 2 years. At last observation, urinary protein excretion was normal in 12 patients and no patient had hematuria. Twelve patients had normal estimated glomerular filtration rate (GFR) and one had renal insufficiency (GFR=38 ml/min per 1.73 m2). A renal biopsy was performed in 11 patients after 2 years of treatment. Activity score decreased from 5.2 to 4.3 (P=0.03) and chronicity score increased from 2.2 to 2.8 (P=0.12). There were no complications of treatment. When compared with a historical group, the treated patients had a significant improvement in urinalysis (P<0.00001) and preservation of normal GFR (P=0.03). We conclude that alternate-day prednisone therapy may benefit patients with IgA nephropathy. A large prospective controlled trial is needed.
Similar content being viewed by others
References
Southwest Pediatric Nephrology Study Group (1982) A multicenter study of IgA nephropathy in children: a report of the Southwest Pediatric Nephrology Study Group. Kidney Int 22:643–652
Droz D (1976) Natural history of primary glomerulonephritis with mesangial deposits of IgA. Contrib Nephrol 2:150–157
Linne' T, Aperia A, Broberger O, Bergstrand A, Bohman SO, Rekola S (1982) Course of renal function in IgA glomerulonephritis in children and adolescents. Acta Paediatr Scand 71:735–743
Peet J van der, Arisz L, Brentjens JRH, Marrink J, Hoedemaeker PJ (1977) The clinical course of IgA nephropathy in adults. Clin Nephrol 8:355–340
Waldo FB, Alexander R, Wyatt RJ, Kohaut EC (1989) Alternate-day prednisone therapy in children with IgA-associated nephritis. Am J Kidney Dis 13:55–60
Andreoli SP, Bergstein JM (1989) Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248–253
Kobayashi Y, Fujii K, Hiki Y, Tateno S (1986) Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases. Q J Med 61:935–943
Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 34:571–590
Houser M (1984) Assessment of proteinuria using random urine samples. J Pediatr 104:845–848
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bryson Waldo, F., Wyatt, R.J., Kelly, D.R. et al. Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone. Pediatr Nephrol 7, 529–532 (1993). https://doi.org/10.1007/BF00852535
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00852535